Literature DB >> 27472880

Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment.

Ping Ren1, Raymond Y Lo2, Benjamin P Chapman3,4, Mark Mapstone5, Anton Porsteinsson3, Feng Lin1,3,6.   

Abstract

The striatum is a critical functional hub in understanding neurological disorders. However, the Alzheimer's disease (AD)-associated striatal change is unclear, as is the relationship between striatal change and AD pathology. Three-year resting-state fMRI data from 15 healthy control (HC) and 20 mild cognitive impairment (MCI) participants were obtained. We analyzed the amplitude of low-frequency fluctuations (ALFF) (0.01-0.08 Hz) and two subdivided bands (slow-4:0.027-0.073 Hz; slow-5:0.01-0.027 Hz). We calculated Aβ/pTau ratio using baseline cerebrospinal fluid pTau and Aβ1-42 to represent AD pathology. Compared to HC, MCI participants showed greater decline in right putaminal ALFF, including the slow-4 band. Greater decline of ALFF in the right putamen was significantly related to the memory decline over time and lower baseline Aβ/pTau ratio regardless of age or group. The slow-4 band, relative to slow-5 band, showed a stronger correlation between Aβ/pTau ratio and decline of ALFF in the right putamen. The results suggest that the putaminal function declines early in the AD-associated neurodegeneration. The continuous decline in putaminal ALFF, especially slow-4 band, may be a sensitive marker of AD pathology such as Aβ/pTau ratio regardless of clinical diagnosis.

Entities:  

Keywords:  Amyloid-beta; low-frequency fluctuation; mild cognitive impairment; pTau; resting state fMRI; striatum

Mesh:

Substances:

Year:  2016        PMID: 27472880      PMCID: PMC5003682          DOI: 10.3233/JAD-160368

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  47 in total

1.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications.

Authors:  Ronald B Postuma; Alain Dagher
Journal:  Cereb Cortex       Date:  2005-12-22       Impact factor: 5.357

3.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Authors:  Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2007-01-08

4.  FMRI connectivity analysis of acupuncture effects on the whole brain network in mild cognitive impairment patients.

Authors:  Yuanyuan Feng; Lijun Bai; Yanshuang Ren; Shangjie Chen; Hu Wang; Wensheng Zhang; Jie Tian
Journal:  Magn Reson Imaging       Date:  2012-03-27       Impact factor: 2.546

5.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Stefan J Teipel; Christine Born; Michael Ewers; Arun L W Bokde; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

6.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

7.  Longitudinal effects of metabolic syndrome on Alzheimer and vascular related brain pathology.

Authors:  Feng Lin; Raymond Y Lo; Daniel Cole; Simon Ducharme; Ding-Geng Chen; Mark Mapstone; Anton Porsteinsson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-06-28

8.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study.

Authors:  L W de Jong; K van der Hiele; I M Veer; J J Houwing; R G J Westendorp; E L E M Bollen; P W de Bruin; H A M Middelkoop; M A van Buchem; J van der Grond
Journal:  Brain       Date:  2008-11-20       Impact factor: 13.501

Review 9.  Network-based biomarkers in Alzheimer's disease: review and future directions.

Authors:  Jaime Gomez-Ramirez; Jinglong Wu
Journal:  Front Aging Neurosci       Date:  2014-02-04       Impact factor: 5.750

10.  Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Authors:  Elena Rodriguez-Vieitez; Laure Saint-Aubert; Stephen F Carter; Ove Almkvist; Karim Farid; Michael Schöll; Konstantinos Chiotis; Steinunn Thordardottir; Caroline Graff; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Brain       Date:  2016-01-26       Impact factor: 13.501

View more
  14 in total

1.  Immediate Abnormal Intrinsic Brain Activity Patterns in Patients with End-stage Renal Disease During a Single Dialysis Session : Resting-state Functional MRI Study.

Authors:  Cong Peng; Hua Yang; Qian Ran; Ling Zhang; Chengxuan Liu; Yu Fang; Yingjiang Liu; Yi Cao; Renrong Liang; He Ren; Qinqin Hu; Xiuting Mei; Yang Jiang; Tianyou Luo
Journal:  Clin Neuroradiol       Date:  2020-07-03       Impact factor: 3.649

2.  Acute Affective Reactivity and Quality of Life in Older Adults with Amnestic Mild Cognitive Impairment: A Functional MRI Study.

Authors:  Ping Ren; Kathi L Heffner; Alanna Jacobs; Feng Lin
Journal:  Am J Geriatr Psychiatry       Date:  2017-06-27       Impact factor: 4.105

3.  Identify a shared neural circuit linking multiple neuropsychiatric symptoms with Alzheimer's pathology.

Authors:  Xixi Wang; Ping Ren; Mark Mapstone; Yeates Conwell; Anton P Porsteinsson; John J Foxe; Rajeev D S Raizada; Feng Lin
Journal:  Brain Imaging Behav       Date:  2019-02       Impact factor: 3.978

4.  Longitudinal Functional Brain Mapping in Supernormals.

Authors:  Xixi Wang; Ping Ren; Timothy M Baran; Rajeev D S Raizada; Mark Mapstone; Feng Lin
Journal:  Cereb Cortex       Date:  2019-01-01       Impact factor: 5.357

5.  Cortical thickness is associated with altered autonomic function in cognitively impaired and non-impaired older adults.

Authors:  Feng Lin; Ping Ren; Xixi Wang; Mia Anthony; Duje Tadin; Kathi L Heffner
Journal:  J Physiol       Date:  2017-10-25       Impact factor: 5.182

6.  Neurofilament relates to white matter microstructure in older adults.

Authors:  Elizabeth E Moore; Timothy J Hohman; Faizan S Badami; Kimberly R Pechman; Katie E Osborn; Lealani Mae Y Acosta; Susan P Bell; Michelle A Babicz; Katherine A Gifford; Adam W Anderson; Lee E Goldstein; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

7.  Alterations of regional homogeneity in Parkinson's disease with mild cognitive impairment: a preliminary resting-state fMRI study.

Authors:  Ming-Ge Li; Tie-Fang Liu; Tian-Hao Zhang; Zhi-Ye Chen; Bin-Bin Nie; Xin Lou; Zhen-Fu Wang; Lin Ma
Journal:  Neuroradiology       Date:  2019-12-10       Impact factor: 2.804

8.  DREAM : A Toolbox to Decode Rhythms of the Brain System.

Authors:  Zhu-Qing Gong; Peng Gao; Chao Jiang; Xiu-Xia Xing; Hao-Ming Dong; Tonya White; F Xavier Castellanos; Hai-Fang Li; Xi-Nian Zuo
Journal:  Neuroinformatics       Date:  2021-01-07

9.  Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson's Disease.

Authors:  Deborah L Harrington; Qian Shen; Gabriel N Castillo; J Vincent Filoteo; Irene Litvan; Colleen Takahashi; Chelsea French
Journal:  Front Aging Neurosci       Date:  2017-06-19       Impact factor: 5.750

10.  Changes of Regional Neural Activity Homogeneity in Preclinical Alzheimer's Disease: Compensation and Dysfunction.

Authors:  Zhen Zhang; Liang Cui; Yanlu Huang; Yu Chen; Yuehua Li; Qihao Guo
Journal:  Front Neurosci       Date:  2021-06-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.